175 related articles for article (PubMed ID: 26911995)
1. Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis.
Khamis RY; Woollard KJ; Hyde GD; Boyle JJ; Bicknell C; Chang SH; Malik TH; Hara T; Mauskapf A; Granger DW; Johnson JL; Ntziachristos V; Matthews PM; Jaffer FA; Haskard DO
Sci Rep; 2016 Feb; 6():21785. PubMed ID: 26911995
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
[TBL] [Abstract][Full Text] [Related]
3. Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein.
Chang SH; Johns M; Boyle JJ; McConnell E; Kirkham PA; Bicknell C; Zahoor-ul-Hassan Dogar M; Edwards RJ; Gale-Grant O; Khamis R; Ramkhelawon KV; Haskard DO
Hybridoma (Larchmt); 2012 Apr; 31(2):87-98. PubMed ID: 22509912
[TBL] [Abstract][Full Text] [Related]
4. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
Tsimikas S; Palinski W; Witztum JL
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
[TBL] [Abstract][Full Text] [Related]
5. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
[TBL] [Abstract][Full Text] [Related]
6. Targeting Elastase for Molecular Imaging of Early Atherosclerotic Lesions.
Glinzer A; Ma X; Prakash J; Kimm MA; Lohöfer F; Kosanke K; Pelisek J; Thon MP; Vorlova S; Heinze KG; Eckstein HH; Gee MW; Ntziachristos V; Zernecke A; Wildgruber M
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):525-533. PubMed ID: 28062502
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal Autoantibody Against a Cryptic Epitope on Tissue-Adherent Low-Density Lipoprotein for Molecular Imaging in Atherosclerosis.
Khamis RY; Hartley A; Caga-Anan M; Pandey SS; Marceddu C; Kojima C; Chang SH; Boyle JJ; Johnson JL; Björkbacka H; Guo L; Finn AV; Virmani R; Nilsson J; Haskard DO
JACC Cardiovasc Imaging; 2022 Aug; 15(8):1458-1470. PubMed ID: 35926905
[TBL] [Abstract][Full Text] [Related]
8. Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo.
Maafi F; Li B; Gebhard C; Brodeur MR; Nachar W; Villeneuve L; Lesage F; Rhainds D; Rhéaume E; Tardif JC
Atherosclerosis; 2017 Mar; 258():8-19. PubMed ID: 28167355
[TBL] [Abstract][Full Text] [Related]
9. Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet.
Ma Y; Wang W; Zhang J; Lu Y; Wu W; Yan H; Wang Y
PLoS One; 2012; 7(4):e35835. PubMed ID: 22558236
[TBL] [Abstract][Full Text] [Related]
10. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.
Tsimikas S; Shortal BP; Witztum JL; Palinski W
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):689-97. PubMed ID: 10712392
[TBL] [Abstract][Full Text] [Related]
11. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
[TBL] [Abstract][Full Text] [Related]
12. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
13. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
[TBL] [Abstract][Full Text] [Related]
14. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
Deguchi JO; Aikawa M; Tung CH; Aikawa E; Kim DE; Ntziachristos V; Weissleder R; Libby P
Circulation; 2006 Jul; 114(1):55-62. PubMed ID: 16801460
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Near-Infrared Fluorescence Imaging of Atherosclerosis Using Local Delivery of Novel Targeted Molecular Probes.
Bertrand MJ; Abran M; Maafi F; Busseuil D; Merlet N; Mihalache-Avram T; Geoffroy P; Tardif PL; Abulrob A; Arbabi-Ghahroudi M; Ni F; Sirois M; L'Allier PL; Rhéaume É; Lesage F; Tardif JC
Sci Rep; 2019 Feb; 9(1):2670. PubMed ID: 30804367
[TBL] [Abstract][Full Text] [Related]
16. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
Palinski W; Miller E; Witztum JL
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):821-5. PubMed ID: 7846059
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
18. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
[TBL] [Abstract][Full Text] [Related]
19. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis.
Palinski W; Tangirala RK; Miller E; Young SG; Witztum JL
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1569-76. PubMed ID: 7583529
[TBL] [Abstract][Full Text] [Related]
20. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
